Pharmacogenomic Testing: Delivering Precision Medicine

By reducing adverse drug responses, improving efficacy, and ensuring each patient gets the drug they are most likely to respond to, pharmacogenomics testing helps deliver the promise of precision medicine. In order to help empower the personalization of cancer treatment, we offer pharmacogenomic testing for doctors, hospitals, and cancer centers, as well as for biopharma and biotech companies engaged in oncology-focused clinical trials.

Below is a sample of the pharmacogenomic genotyping assays we offer for oncology testing. In addition to conventional pharmacogenomics tests, we are experienced in providing custom assay development and validation. For questions or more information about pharmacogenomic testing for oncology clinical trials, please contact us.

ABCB1
ABCC2
ATM
ATR
CD86
CDA
CHEK1
CHEK2
CTLA4
CYP2A6
CYP2B6
CYP2C19
CYP2C8
CYP2D6
CYP3A4
CYP3A5
DPD
ERCC1
ERCC2
FCGR2A
FCGR2B
FCGR3A
GST
ITPA
MTHFR
NAT1
NAT2
OPRT-213/UMPS-213
PON1
TS
UGT1A1
UGT1A4
VEGFR1
XRCC1